We are live on ! Find out more
RHBC

R.H. Bluestein & Co Portfolio holdings

AUM $1.61B
1-Year Est. Return 7.59%
This Fund
S&P 500
This Quarter Est. Return
+5.56%
1 Year Est. Return
-7.59%
3 Year Est. Return
+69.02%
5 Year Est. Return
+139.59%
10 Year Est. Return
AUM
$1.6B
AUM Growth
+$2.73M
Cap. Flow
-$57.6M
Cap. Flow %
-3.6%
Top 10 Hldgs %
27.48%
Holding
400
New
43
Increased
63
Reduced
145
Closed
50

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$20.3M
2
NEE icon
NextEra Energy
NEE
+$19.1M
3
DD icon
DuPont de Nemours
DD
+$14.5M
4
MMM icon
3M
MMM
+$13.4M
5
BUD icon
AB InBev
BUD
+$9.22M

Sector Composition

Rank Sector Weight
1 Industrials 22.78%
2 Healthcare 12.8%
3 Consumer Staples 10%
4 Consumer Discretionary 9.98%
5 Technology 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PG icon
51
Procter & Gamble
PG
$340B
$9.11M 0.57%
99,956
+95,545
+2,166% +$8.41M
AZN icon
52
AstraZeneca
AZN
$269B
$7.68M 0.48%
109,195
+99,195
+992% +$7.1M
BRK.B icon
53
Berkshire Hathaway Class B
BRK.B
$1.1T
$6.96M 0.44%
46,325
+44,875
+3,095% +$6.48M
RTN
54
DELISTED
Raytheon Company
RTN
$5.41M 0.34%
50,000
+46,500
+1,329% +$4.8M
SBUX icon
55
Starbucks
SBUX
$119B
$4.36M 0.27%
+106,250
New +$4.15M
ADP icon
56
Automatic Data Processing
ADP
$109B
$4.08M 0.26%
+48,925
New +$3.97M
SWK icon
57
Stanley Black & Decker
SWK
$14.5B
$3.72M 0.23%
+38,750
New +$3.57M
CP icon
58
Canadian Pacific Kansas City
CP
$81B
$3.37M 0.21%
87,500
-90,025
-51% -$3.56M
COP icon
59
ConocoPhillips
COP
$144B
$3.25M 0.2%
+46,985
New +$3.28M
MSI icon
60
Motorola Solutions
MSI
$72.1B
$2.86M 0.18%
42,675
+9,825
+30% +$627K
SNN icon
61
Smith & Nephew
SNN
$13.7B
$2.71M 0.17%
73,900
+53,900
+270% +$1.81M
BRK.A icon
62
Berkshire Hathaway Class A
BRK.A
$1.1T
$2.71M 0.17%
12
-1
-8% -$216K
CNI icon
63
Canadian National Railway
CNI
$78.5B
$2.33M 0.15%
33,850
-16,025
-32% -$1.1M
SU icon
64
Suncor Energy
SU
$77.7B
$2.22M 0.14%
69,775
-129,650
-65% -$4.29M
GNRC icon
65
Generac Holdings
GNRC
$11.5B
$2.22M 0.14%
47,400
-124,740
-72% -$5.46M
TNXP icon
66
Tonix Pharmaceuticals
TNXP
$152M
0
USO icon
67
United States Oil Fund
USO
$2.15B
$2.03M 0.13%
+12,479
New +$2.77M
RH icon
68
RH
RH
$3.33B
$1.87M 0.12%
+19,500
New +$1.63M
CMI icon
69
Cummins
CMI
$83.6B
$1.8M 0.11%
12,480
+9,930
+389% +$1.4M
EBAY icon
70
eBay
EBAY
$51.2B
$1.78M 0.11%
75,448
+31,542
+72% +$716K
LLL
71
DELISTED
L3 Technologies, Inc.
LLL
$1.77M 0.11%
14,020
+10,420
+289% +$1.25M
CHKP icon
72
Check Point Software Technologies
CHKP
$14.3B
$1.71M 0.11%
21,700
-6,500
-23% -$483K
MAS icon
73
Masco
MAS
$14.3B
$1.65M 0.1%
74,340
+54,283
+271% +$1.12M
TTM
74
DELISTED
Tata Motors Limited
TTM
$1.6M 0.1%
37,950
-5,000
-12% -$223K
TT icon
75
Trane Technologies
TT
$98.8B
$1.57M 0.1%
24,765
-12,500
-34% -$763K

Similar funds

R.H. Bluestein & Co's Q4 2014 Portfolio in Review

As of Q4 2014, R.H. Bluestein & Co held 400 positions worth $1.6B, up 0.17% from $1.6B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

R.H. Bluestein & Co withdrew a net $57.6M in Q4 2014, closing 50 positions and reducing 145 holdings. Its most notable exit was Whiting Petroleum Corporation, an estimated $33.7M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Staples.

Against the trend, R.H. Bluestein & Co opened a new position in Axon Enterprise worth $10.2M.

  • R.H. Bluestein & Co's largest Q4 2014 buy was Axon Enterprise: 385,499 shares worth $10.2M.
  • R.H. Bluestein & Co added most to Johnson & Johnson in Q4 2014, an estimated $20.3M increase.
  • R.H. Bluestein & Co's biggest Q4 2014 reduction was Perrigo, cutting an estimated $25.8M.
  • R.H. Bluestein & Co fully exited Whiting Petroleum Corporation in Q4 2014, selling an estimated $33.7M.
  • R.H. Bluestein & Co's ten largest holdings make up 27% of its $1.6B portfolio in Q4 2014.
  • R.H. Bluestein & Co opened 43 new positions and closed 50 in Q4 2014.
  • R.H. Bluestein & Co's portfolio value rose 0.17% quarter-over-quarter to $1.6B.

Based on R.H. Bluestein & Co's 13F filing for Q4 2014, filed 12 Feb 2015.